SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION

BACKGROUND: Hepatitis C virus (HCV) infection became curable because of the development of direct acting antivirals (DAAs). However, the high cost of DAAs has greatly impeded their potential impact on the treatment of HCV infection. As a result, hepatitis C will continue to cause substantial morbidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyero, Olufunmilayo G., Toyama, Masaaki, Mitsuhiro, Naoki, Onifade, Abdulfatah A., Hidaka, Akemi, Okamoto, Mika, Baba, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412185/
https://www.ncbi.nlm.nih.gov/pubmed/28480371
http://dx.doi.org/10.21010/ajtcam.v13i6.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412185/
https://www.ncbi.nlm.nih.gov/pubmed/28480371
http://dx.doi.org/10.21010/ajtcam.v13i6.20

Ejemplares similares